Japan· JP-2144009F1018
テモカプリル塩酸塩
A temocapril product containing テモカプリル塩酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Temocapril is registered in 2 of 19 countries.
Countries holding a registration under ATC C09AA14 (temocapril), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Temocapril · ATC C09AA14
2 / 19 countries
- Finlandprice
- Japan
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- テモカプリル塩酸塩
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- C09AA14
- ATC class
- Temocapril
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
21 interactions on record for temocapril.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Temocapril · interactions on record
21 records
21 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09AA14
Temocapril, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5fe0461-eae8-45ba-a32c-1ec4c69b3ca4 GET /v1/drugs/b5fe0461-eae8-45ba-a32c-1ec4c69b3ca4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2144009F1018",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "テモカプリル塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2144",
"transitional_expiry": null
}See everything about temocapril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.